HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US TELL FRIEND RSS

Welcome to FDAweb Pay Per View Search our 67,560 - story database FREE   Free Items  Warning Letters  FDA Notices  FDA Calendar    FDA Whistleblowers          << Prev  10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 Next >>   Teva Approval for Zecuity Withdrawn [79 Words] [ Price : $8.95] Federal Register notice: FDA withdraws approval of Teva’s NDA for Zecuity (sumatriptan iontophoretic transdermal system) after the company requested its withdrawal. 07/07/2020     Clinical Hold on Cellectis CAR T Cell Therapy [152 Words] [ Price : $8.95] FDA places a clinical hold on a Cellectis multiple myeloma trial (MELANI-01 study) after a study patient died. 07/07/2020     House Appropriators Approve $41 million Boost [420 Words] [ Price : $8.95] A House appropriations subcommittee approves by voice vote a bill that includes an additional $41 million for FDA in fiscal year 2021. 07/07/2020     REMS Web Site Updates Listed [2587 Words] [ Price : $8.95] FDA publishes a list of the latest REMS updates for five drugs. 07/07/2020     Latest FDA Warning Letters [344 Words] [ Price : $8.95] FDA releases its latest batch of Warning Letters that includes Greiner Bio-One, Luminex Corp. and Vega Life Sciences. 07/07/2020     Info Collection on Radioactive Drug Research Committees [80 Words] [ Price : $8.95] Federal Register notice: FDA sends to OMB an information collection extension for “Radioactive Drug Research Committees.” 07/07/2020     QS, MDR Violations at Luminex Corp. [2810 Words] [ Price : $8.95] FDA warns Luminex Corp. about QS and MDR violations in its production of multiplexing systems. 07/07/2020     FDA Alert on BD Covid-19 Reagents [147 Words] [ Price : $8.95] An FDA safety alert warns about an increased risk of a false positive result with Becton Dickinson’s BD SARS-CoV-2 Reagents for the BD Max System test. 07/06/2020     Exceptions to Labeling for Stockpiled Products [110 Words] [ Price : $8.95] Federal Register notice: FDA seeks comments on an information collection extension for “Exceptions or Alternatives To Labeling Requirements for Products Held by the Strategic National Stockpile.” 07/06/2020     Novartis Settles ‘Sham Speaker Programs’ for $678 Million [2701 Words] [ Price : $8.95] The Justice Department says Novartis will pay $678 million to settle a whistleblower suit alleging that it operated a sham speaker program to funnel money and gifts to doctors to encourage them to prescribe Novartis drugs. 07/06/2020     << Prev  10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29  Next >>

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com